Bank of America Merrill Lynch Form 38.5 (b) - Allergan Plc (4502T)

TIDM0Y7T

RNS Number : 4502T

Bank of America Merrill Lynch

14 November 2019

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT

RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 
1.  KEY INFORMATION 
 
 
 Name of exempt principal trader             Bank of America, N.A., Proprietary 
 Company dealt in                            Allergan PLC 
                                            ----------------------------------- 
 Class of relevant security to which the     Common - IE00BY9D5467 
   dealings being disclosed relate(Note 1) 
                                            ----------------------------------- 
 Date of dealing                             13/11/2019 
                                            ----------------------------------- 
 
 
2.  INTERESTS AND SHORT POSITIONS 
 
 
(a)  Interests and short positions (following dealing) 
      in the class of relevant security 
      dealt in (Note 2) 
 
 
 Class of relevant security: Common               IE00BY9D5467 
                                                  Long                 Short 
                                                 -------------------  ------------------- 
                                                  Number      %        Number      % 
                                                 ----------  -------  ----------  ------- 
 (1)  Relevant securities                         4,033,391   1.229%   0           0 % 
                                                 ----------  -------  ----------  ------- 
 (2)  Derivatives (other than options):           1,446,230   0.441%   5,762,689   1.756% 
                                                 ----------  -------  ----------  ------- 
 (3)  Options and agreements to purchase/sell:    0           0%       0           0% 
                                                 ----------  -------  ----------  ------- 
      Total                                       5,479,621   1.669%   5,762,689   1.756% 
                                                 ----------  -------  ----------  ------- 
 
 
(b)  Interests and short positions in relevant securities 
      of the company, other than the 
      class dealt in (Note 2) 
 
 
 Class of relevant security: 
                                                  Long          Short 
                                                 ------------  ------------ 
                                                  Number   %    Number   % 
                                                 -------  ---  -------  --- 
 (1)  Relevant securities                         0        0%   0        0% 
                                                 -------  ---  -------  --- 
 (2)  Derivatives (other than options):           0        0%   0        0% 
                                                 -------  ---  -------  --- 
 (3)  Options and agreements to purchase/sell:    0        0%   0        0% 
                                                 -------  ---  -------  --- 
      Total                                       0        0%   0        0% 
                                                 -------  ---  -------  --- 
 
 
3.  DEALINGS (Note 3) 
 
 
(a)  Purchases and sales 
 
 
 Purchase/sale   Number of relevant securities   Price per unit (Note 4) 
 Purchase        1,155,154                       181.96 USD 
                ------------------------------  ------------------------ 
 
 
 Purchase/sale   Number of relevant securities   Price per unit (Note 4) 
 Sale            1,996                           181.96 USD 
                ------------------------------  ------------------------ 
 Sale            37                              181.96 USD 
                ------------------------------  ------------------------ 
 
 
(b)  Derivatives transactions (other than options transactions) 
 
 
 Product name,   Nature of transaction         Number of relevant securities   Price per unit 
  e.g. CFD        (Note 5)                      (Note 6)                        (Note 4) 
 Swaps           Increasing a Short Position   1,155,117                       181.96 USD 
                ----------------------------  ------------------------------  --------------- 
 Swaps           Increasing a Long Position    12                              181.815 USD 
                ----------------------------  ------------------------------  --------------- 
 
 
(c)  Options transactions in respect of existing relevant 
      securities 
 
 
(i)  Writing, selling, purchasing or varying 
 
 
  Product       Writing,       Number of      Exercise        Type,        Expiry date    Option money paid/ received 
    name,       selling,       securities       price     e.g. American,                       per unit (Note 4) 
  e.g. call    purchasing,      to which                     European 
   option        varying       the option                      etc 
                  etc.        relates (Note 
                                   7) 
    N/A           N/A             N/A           N/A            N/A             N/A                    N/A 
             -------------  ---------------  ---------  ----------------  ------------  ------------------------------ 
 
 
(ii)  Exercising 
 
 
  Product name,        Number of securities    Exercise price per 
   e.g. call option                             unit (Note 4) 
        N/A                    N/A                    N/A 
                     ----------------------  -------------------- 
 
 
(d)  Other dealings (including transactions in respect 
      of new securities) (Note 3) 
 
 
  Nature or transaction    Details    Price per unit 
   (Note 7)                            (if applicable) (Note 4) 
          N/A               N/A                 N/A 
                         ---------  --------------------------- 
 
 
4.  OTHER INFORMATION 
 

Agreements, arrangements or understandings relating to options or derivatives

 
 Full details of any agreement, arrangement or understanding between the person 
  disclosing and any other person relating to the voting rights of any relevant 
  securities under any option referred to on this form or relating to the voting rights 
  or future acquisition or disposal of any relevant securities to which any derivative 
  referred to on this form is referenced. If none, this should be stated. 
 None 
 
 
Is a Supplemental Form 38.5(b) attached? (Note 8)  No 
 
 
 Date of disclosure                              14/11/2019 
 Contact name                                    Tolu Tade 
                                                ------------------------ 
 Telephone number                                [phone] 
                                                ------------------------ 
 Name of offeree/offeror with which connected    AbbVie Inc 
                                                ------------------------ 
 Nature of connection (Note 9)                   Advisor to - AbbVie Inc 
                                                ------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

ISEFMMMMMDNGLZM

(END) Dow Jones Newswires

November 14, 2019 06:38 ET (11:38 GMT)